Insulin therapy contributes to the increased risk of colorectal cancer in diabetes patients: A meta-analysis

Diagnostic Pathology

Volumn 8, Issue 1, 2013, Pages

  Wang, Lei ^a   Cai, Shuang ^a   Teng, Zan ^a   Zhao, Xin ^a   Chen, Xinyue ^a   Bai, Xiaojuan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

CASE CONTROL STUDY; COLORECTAL TUMOR; DIABETES MELLITUS; HUMAN; META ANALYSIS; REVIEW; RISK FACTOR;

CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; RISK FACTORS;

EID: 84886737125     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-8-180     Document Type: Article

References (18)

1. World Cancer Research Fund/American Institute for Cancer Research Food, nutrition, physical activity, and the prevention of cancer: a global perspective 2007, Washington, DC: AICR, World Cancer Research Fund/American Institute for Cancer Research.
2. Yang YX, Hennessy S, Lewis JD. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology 2004, 127:1044-1050. 10.1053/j.gastro.2004.07.011, 15480982.
3. Oliveria SA, Koro CE, Ulcickas Yood M, Sowell M. Cancer incidence among patients treated with antidiabetic pharmacotherapy. Diabetes Metab Syndr Clin Res Rev 2008, 2:47-57.
4. Currie CJ, Poole CD, Gale EA. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 2009, 52:1766-1777. 10.1007/s00125-009-1440-6, 19572116.
5. Tran TT, Medline A, Bruce WR. Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomarkers Prev 1996, 5:1013-1015.
6. Tran TT, Naigamwalla D, Oprescu AI, et al. Hyperinsulinemia, but not other factors associated with insulin resistance, acutely enhances colorectal epithelial proliferation in vivo. Endocrinology 2006, 147:1830-1837.
7. National Institute of Diabetes and Digestive and Kidney Diseases National Diabetes Statistics, 2007 fact sheet 2008, Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.
8. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188. 10.1016/0197-2456(86)90046-2, 3802833.
9. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558. 10.1002/sim.1186, 12111919.
10. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997, 315:629-634.
11. Egger M, Smith GD, Altman DG. Systematic reviews in health care: meta-analysis in context 2001, London: BMJ.
12. Sutton AJ, Duval SJ, Tweedie RL, Abrams KR, Jones DR. Empirical assessment of effect of publication bias on meta-analyses. BMJ 2000, 320:1574. 10.1136/bmj.320.7249.1574, 27401, 10845965.
13. Chung YW, Han DS, Park KH, Eun CS, Yoo KS, Park CK. Insulin therapy and colorectal adenoma risk among patients with type 2 diabetes mellitus: a case-control study in Korea. Dis Colon Rect 2008, 51:593-597.
14. Campbell PT, Deka A, Jacobs EJ, et al. Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men. Gastroenterology 2010, 139:1138-1146. 10.1053/j.gastro.2010.06.072, 20633560.
15. Liwa Y, Chen J. Association of MHTFR Ala222Val (rs1801133) polymorphism and breast cancer susceptibility: An update meta-analysis based on 51 research studies. Diagn Pathol 2012, 7:171. 10.1186/1746-1596-7-171, 3536596, 23217001.
16. Qin X, Peng Q, Qin A, Chen Z, Lin L, et al. Association of COMT Val158Met polymorphism and breast cancer risk: an updated meta-analysis. Diagn Pathol 2012, 7:136. 10.1186/1746-1596-7-136, 3543196, 23039364.
17. de Matos L, Del Giglio A, Matsubayashi C, de Lima Farah M, Del Giglio A, et al. Expression of ck-19, galectin-3 and hbme-1 in the differentiation of thyroid lesions: systematic review and diagnostic meta-analysis. Diagn Pathol 2012, 7:97. 10.1186/1746-1596-7-97, 3523001, 22888980.
18. Jin F, Qu L-S, Shen X-Z. Association between the methylenetetrahydrofolate reductase C677T polymorphism and hepatocellular carcinoma risk: a meta-analysis. Diagn Pathol 2009, 4:39. 10.1186/1746-1596-4-39, 2788519, 19930673.